The Impact of a Topical Vasodilating Cream on Female Sexual Experience

NCT ID: NCT01078077

Last Updated: 2012-03-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-03-31

Study Completion Date

2012-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if a topical vasodilating cream will improve female sexual experience.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To determine in a placebo controlled double blinded study whether a topically applied vasodilating cream will improve the female sexual response as measured by a standard female sexual dysfunction questionnaire

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Female Sexual Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy females ages 25 to sixty sexually active

Exclusion Criteria

* Neurologic disease, on SSRI's,advanced diabetes, non sexually active, mentally incompetent
Minimum Eligible Age

25 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

West Penn Allegheny Health System

OTHER

Sponsor Role collaborator

Michael Pelekanos MD

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michael Pelekanos MD

michael pelekanos MD, WPAHS

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

michael j pelekanos, MD

Role: PRINCIPAL_INVESTIGATOR

east surburban obgyn

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

East Suburban Obgyn

Monroeville, Pennsylvania, United States

Site Status RECRUITING

West Penn Allegheny Health Center

Monroeville, Pennsylvania, United States

Site Status RECRUITING

West Penn Hospital Forbes Campus

Monroeville, Pennsylvania, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

michael j pelekanos, MD

Role: CONTACT

4128567500

Guy Stofman, MD

Role: CONTACT

4123706313

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Michael J Pelekanos, MD

Role: primary

412-779-1034

Guy Stoffman, MD

Role: backup

412 3706313

pelekanos

Role: primary

412-856-7500

vickie lathom

Role: backup

4128567500

michael j pelekanos, md

Role: primary

412-856-7500

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10-005

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Topical Estriol for Vaginal Health
NCT00908570 COMPLETED PHASE1
Topical Ketotifen 0.25% for Secondary Vestibulodynia
NCT07257029 NOT_YET_RECRUITING PHASE2
CC-10004 For The Treatment Of Vulvodynia
NCT00814632 COMPLETED PHASE2